260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer

• Herbert Zeh,
• Nathan Bahary,
• Michael Lotze,
• Amer Zureikat,
• Miranda Byrne-Steele,
• Wenjing Pan,
• Jian Han,
• Pranav Murthy,
• Pragosh Saini,
• Kira Russell,
• Daniel Weber,
• Viginia Espina,
• Lance Liotta,
• Aatur Singhi

Affiliations

Herbert Zeh

4University of Texas Southwestern Medical Center, Dallas, TX, USA

Nathan Bahary

1University of Pittsburgh, Pittsburgh, PA, USA

Michael Lotze

Aff5 grid.21925.3d0000000419369000Departments of Surgery, Immunology and BioengineeringUniversity of Pittsburgh PA USA

Amer Zureikat

Aff72 grid.478063.e0000000404569819University of Pittsburgh Cancer Institute Pittsburgh PA USA

Miranda Byrne-Steele

Aff239 grid.429220.fiRepertoire, Inc Huntsville AL USA

Wenjing Pan

Aff239 grid.429220.fiRepertoire, Inc Huntsville AL USA

Jian Han

Aff239 grid.429220.fiRepertoire, Inc Huntsville AL USA

Pranav Murthy

1University of Pittsburgh, Pittsburgh, PA, USA

Pragosh Saini

1University of Pittsburgh, Pittsburgh, PA, USA

Kira Russell

1University of Pittsburgh, Pittsburgh, PA, USA

Daniel Weber

2HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA

Viginia Espina

3George Mason University, Manassas, VA, USA

Lance Liotta

3George Mason University, Manassas, VA, USA

Aatur Singhi

1University of Pittsburgh, Pittsburgh, PA, USA